series-a
Stage
1
Investors
About
Aikium develops an AI-driven platform that integrates deep learning with ultra-large-scale wet lab experiments to design and screen protein therapeutics targeting hard-to-drug disease-associated proteins, including GPCRs and ion channels.
Explore Aikium's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.